Targeting delivery of tocopherol and doxorubicin grafted-chitosan polymeric micelles for cancer therapy: In vitro and in vivo evaluation

Colloids and Surfaces B: Biointerfaces

Volumn 133, Issue , 2015, Pages 254-262

  Nam, Joung Pyo ^a   Lee, Kyeong Jae ^a   Choi, Joung Woo ^b   Yun, Chae Ok ^b   Nah, Jae Woon ^a  

^a Sunchon National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Chitosan; Doxorubicin; PH sensitive; Targeted delivery

Indexed keywords

CHITIN; CHITOSAN; DISEASES; MOLECULAR BIOLOGY; PEPTIDES; POLYMERS; TUMORS;

ANTICANCER ACTIVITIES; CONFOCAL LASER SCANNING MICROSCOPY; DOXORUBICIN; HUMAN EPIDERMAL GROWTH FACTOR; PH SENSITIVE; RECEPTOR-MEDIATED ENDOCYTOSIS; TARGETED DELIVERY; TARGETED DRUG DELIVERY SYSTEMS;

MICELLES;

CHITOSAN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; POLYMER; TOCOPHEROL; MICELLE;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BREAST CANCER; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN TARGETING; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; HEK293 CELL LINE; NEOPLASMS; TUMOR CELL LINE;

MUS;

CELL LINE, TUMOR; CHITOSAN; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HEK293 CELLS; HUMANS; IN VITRO TECHNIQUES; MICELLES; NEOPLASMS; POLYMERS; TOCOPHEROLS;

EID: 84934927558     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.06.018     Document Type: Article

References (42)

1. Wang Y.C., Wang F., Sun T.M., Wang J. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjugate Chem. 2011, 22:1939-1945.
2. Su Y., Hu Y., Du Y., Huang X., He J., You J., Yuan H., Hu F. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy. Mol. Pharm. 2015, 12:1193-1202.
3. Barba A.A., Dalmoro A., d'Amore M., Lamberti G. In vitro dissolution of pH sensitive microparticles for colon-specific drug delivery. Pharm. Dev. Technol. 2012.
4. Amoozgar Z., Park J., Lin Q., Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Mol. Pharm. 2012, 9:1262-1270.
5. Balamuralidhara V., Pramodkumar T.M., Srujana N., Venkatesh M.P., Vishal Gupta N., Krishna K.L., Gangadharappa H.V. pH sensitive drug delivery systems: a review. Am. J. Drug Discov. Dev. 2011, 1:24-48.
6. Kwon G.S., Okano T. Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev. 1996, 21:107-116.
7. Hruby M., Konak C., Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 2005, 103:137-148.
8. Kataoka K., Matsumoto T., Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., Kwon G.S. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release 2000, 64:143-153.
9. Yue J., Liu S., Wang R., Hu X., Xie Z., Huang Y., Jing X. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models. Mol. Pharm. 2012.
10. Chen D., Song P., Jiang F., Meng X., Sui W., Shu C., Wan L.J. pH-responsive mechanism of a deoxycholic acid and folate comodified chitosan micelle under cancerous environment. J. Phys. Chem. B 2013, 117:1261-1268.
11. Du Y.Z., Cai L.L., Li J., Zhao M.D., Chen F.Y., Yuan H., Hu F.Q. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int. J. Nanomed. 2011, 6:1559-1568.
12. Yang R., Meng F., Ma S., Huang F., Liu H., Zhong Z. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(epsilon-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Biomacromolecules 2011, 12:3047-3055.
13. Yu S.S., Lau C.M., Barham W.J., Onishko H.M., Nelson C.E., Li H., Smith C.A., Yull F.E., Duvall C.L., Giorgio T.D. Macrophage-specific RNA interference targeting via click, mannosylated polymeric micelles. Mol. Pharm 2013, 10:975-987.
14. Yousefpour P., Atyabi F., Vasheghani-Farahani E., Movahedi A.A., Dinarvand R. Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int. J. Nanomed. 2011, 6:1977-1990.
15. Hoppe-Seiler F. Chitin and chitosan. Ber. Dtsch Chem. Ges. 1994, 27:3329-3331.
16. Domard A., Cartier N. Glucosamine oligomers: 4. Solid state-crystallization and sustained dissolution. Int. J. Biol. Macromol. 1992, 14:100-106.
17. Hejazi R., Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 2003, 89:151-165.
18. Chen L., Du Y., Tian Z., Sun L. Effect of the degree of deacetylation and the substitution of carboxymethyl chitosan on its aggregation behavior. J. Polym. Sci. B 2005, 43:296-305.
19. Chen X.-G., Park H.-J. Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions. Carbohydr. Polym. 2003, 53:355-359.
20. Fei Liu X., Lin Guan Y., Zhi Yang D., Li Z., De Yao K. Antibacterial action of chitosan and carboxymethylated chitosan. J. Appl. Polym. Sci. 2001, 79:1324-1335.
21. Arcamone F. Doxorubicin 1981, Academic Press, New York.
22. Von Hoff D.D., Rozencweig M., Piccart M. The cardiotoxicity of anticancer agents. Semin. Oncol. 1982, 9:23-33.
23. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G.M., et al. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 1989, 81:116-124.
24. Qiu L., Wu X., Jin Y. Doxorubicin-loaded polymeric micelles based on amphiphilic polyphosphazenes with poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) and ethyl glycinate as side groups: synthesis, preparation and in vitro evaluation. Pharm. Res. 2009, 26:946-957.
25. Kim D., Gao Z.G., Lee E.S., Bae Y.H. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol. Pharm. 2009, 6:1353-1362.
26. Cammas S., Matsumoto T., Okano T., Sakurai Y., Kataoka K. Design of functional polymeric micelles as site-specific drug vehicles based on poly (α-hydroxy ethylene oxide-co-β-benzyl l-aspartate) block copolymers. Mater. Sci. Eng. C 1997, 4:241-247.
27. Prasad K.N., Kumar B., Yan X.D., Hanson A.J., Cole W.C. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J. Am. Coll. Nutr. 2003, 22:108-117.
28. Turley J.M., Ruscetti F.W., Kim S.J., Fu T., Gou F.V., Birchenall-Roberts M.C. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res. 1997, 57:2668-2675.
29. Turley J.M., Fu T., Ruscetti F.W., Mikovits J.A., Bertolette D.C., Birchenall-Roberts M.C. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res. 1997, 57:881-890.
30. Fariss M.W., Fortuna M.B., Everett C.K., Smith J.D., Trent D.F., Djuric Z. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res. 1994, 54:3346-3351.
31. Muthiah M., Che H.L., Kalash S., Jo J., Choi S.Y., Kim W.J., Cho C.S., Lee J.Y., Park I.K. Formulation of glutathione responsive anti-proliferative nanoparticles from thiolated Akt1 siRNA and disulfide-crosslinked PEI for efficient anti-cancer gene therapy. Colloids Surf. B 2015, 126:322-327.
32. Kim T.I., Rothmund T., Kissel T., Kim S.W. Bioreducible polymers with cell penetrating and endosome buffering functionality for gene delivery systems. J. Control. Release 2011, 152:110-119.
33. Nam J.P., Kim D.G., Kim Y.B., Jeong Y.I., Jang M.K., Nah J.W. Preparation and NMR spectroscopic characterization of low molecular water soluble O-carboxymethyl chitosan. J. Chitin Chitosan 2008, 13:105-109.
34. Burt H.M., Zhang X., Toleikis P., Embree L., Hunter W.L. Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf. B 1999, 16:161-171.
35. Park S.C., Kim J.Y., Jeong C., Yoo S., Hahm K.S., Park Y. A plausible mode of action of pseudin-2, an antimicrobial peptide from Pseudis paradoxa. Biochim. Biophys. Acta 2011, 1808:171-182.
36. Choi J.W., Kang E., Kwon O.J., Yun T.J., Park H.K., Kim P.H., Kim S.W., Kim J.H., Yun C.O. Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy. Gene Ther. 2013.
37. Arya G., Vandana M., Acharya S., Sahoo S.K. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine 2011, 7:859-870.
38. Tao Y., Han J., Dou H. Paclitaxel-loaded tocopheryl succinate-conjugated chitosan oligosaccharide nanoparticles for synergistic chemotherapy. J. Mater. Chem. 2012, 22:8930.
39. Yuan H., Lu L.J., Du Y.Z., Hu F.Q. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption. Mol. Pharm. 2011, 8:225-238.
40. Hu F.Q., Zhang Y.Y., You J., Yuan H., Du Y.Z. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Mol. Pharm. 2012, 9:2469-2478.
41. West K.R., Otto S. Reversible covalent chemistry in drug delivery. Curr. Drug Discov. Technol. 2005, 2:123-160.
42. Tai W., Mahato R., Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J. Control. Release 2010, 146:264-275.